232 related articles for article (PubMed ID: 28000847)
1. PI3K/AKT signaling mediated by G protein‑coupled receptors is involved in neurodegenerative Parkinson's disease (Review).
Nakano N; Matsuda S; Ichimura M; Minami A; Ogino M; Murai T; Kitagishi Y
Int J Mol Med; 2017 Feb; 39(2):253-260. PubMed ID: 28000847
[TBL] [Abstract][Full Text] [Related]
2. The PI3K-AKT pathway: A plausible therapeutic target in Parkinson's disease.
Goyal A; Agrawal A; Verma A; Dubey N
Exp Mol Pathol; 2023 Feb; 129():104846. PubMed ID: 36436571
[TBL] [Abstract][Full Text] [Related]
3. Activation of Sonic hedgehog signal by Purmorphamine, in a mouse model of Parkinson's disease, protects dopaminergic neurons and attenuates inflammatory response by mediating PI3K/AKt signaling pathway.
Shao S; Wang GL; Raymond C; Deng XH; Zhu XL; Wang D; Hong LP
Mol Med Rep; 2017 Aug; 16(2):1269-1277. PubMed ID: 28627590
[TBL] [Abstract][Full Text] [Related]
4. Roles of PTEN with DNA Repair in Parkinson's Disease.
Ogino M; Ichimura M; Nakano N; Minami A; Kitagishi Y; Matsuda S
Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27314344
[TBL] [Abstract][Full Text] [Related]
5. Sulfated Hetero-Polysaccharides Protect SH-SY5Y Cells from H₂O₂-Induced Apoptosis by Affecting the PI3K/Akt Signaling Pathway.
Wang J; Liu H; Zhang X; Li X; Geng L; Zhang H; Zhang Q
Mar Drugs; 2017 Apr; 15(4):. PubMed ID: 28383489
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of Drosophila DJ-1 leads to impairments of oxidative stress response and phosphatidylinositol 3-kinase/Akt signaling.
Yang Y; Gehrke S; Haque ME; Imai Y; Kosek J; Yang L; Beal MF; Nishimura I; Wakamatsu K; Ito S; Takahashi R; Lu B
Proc Natl Acad Sci U S A; 2005 Sep; 102(38):13670-5. PubMed ID: 16155123
[TBL] [Abstract][Full Text] [Related]
7. Expression changes of genes associated with apoptosis and survival processes in Parkinson's disease.
Yalçınkaya N; Haytural H; Bilgiç B; Özdemir Ö; Hanağası H; Küçükali Cİ; Özbek Z; Akcan U; İdrisoğlu HA; Gürvit H; Tüzün E
Neurosci Lett; 2016 Feb; 615():72-7. PubMed ID: 26806867
[TBL] [Abstract][Full Text] [Related]
8. Curcumin can improve Parkinson's disease via activating BDNF/PI3k/Akt signaling pathways.
Jin T; Zhang Y; Botchway BOA; Zhang J; Fan R; Zhang Y; Liu X
Food Chem Toxicol; 2022 Jun; 164():113091. PubMed ID: 35526734
[TBL] [Abstract][Full Text] [Related]
9. The estrogen receptor β-PI3K/Akt pathway mediates the cytoprotective effects of tocotrienol in a cellular Parkinson's disease model.
Nakaso K; Tajima N; Horikoshi Y; Nakasone M; Hanaki T; Kamizaki K; Matsura T
Biochim Biophys Acta; 2014 Sep; 1842(9):1303-12. PubMed ID: 24768803
[TBL] [Abstract][Full Text] [Related]
10. Lentiviral Vector-Mediated SHC3 Silencing Exacerbates Oxidative Stress Injury in Nigral Dopamine Neurons by Regulating the PI3K-AKT-FoxO Signaling Pathway in Rats with Parkinson's Disease.
Gong J; Zhang L; Zhang Q; Li X; Xia XJ; Liu YY; Yang QS
Cell Physiol Biochem; 2018; 49(3):971-984. PubMed ID: 30184529
[TBL] [Abstract][Full Text] [Related]
11. Danshensu protects against 6-hydroxydopamine-induced damage of PC12 cells in vitro and dopaminergic neurons in zebrafish.
Chong CM; Zhou ZY; Razmovski-Naumovski V; Cui GZ; Zhang LQ; Sa F; Hoi PM; Chan K; Lee SM
Neurosci Lett; 2013 May; 543():121-5. PubMed ID: 23562886
[TBL] [Abstract][Full Text] [Related]
12. Bromocriptine activates NQO1 via Nrf2-PI3K/Akt signaling: novel cytoprotective mechanism against oxidative damage.
Lim JH; Kim KM; Kim SW; Hwang O; Choi HJ
Pharmacol Res; 2008 May; 57(5):325-31. PubMed ID: 18455424
[TBL] [Abstract][Full Text] [Related]
13. Protective Effect of Tocotrienol on In Vitro and In Vivo Models of Parkinson's Disease.
Matsura T
J Nutr Sci Vitaminol (Tokyo); 2019; 65(Supplement):S51-S53. PubMed ID: 31619646
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotection by tetrahydroxystilbene glucoside in the MPTP mouse model of Parkinson's disease.
Zhang L; Huang L; Chen L; Hao D; Chen J
Toxicol Lett; 2013 Oct; 222(2):155-63. PubMed ID: 23911879
[TBL] [Abstract][Full Text] [Related]
15. Taurine protects dopaminergic neurons in paraquat-induced Parkinson's disease mouse model through PI3K/Akt signaling pathways.
Wang K; Zhang B; Tian T; Zhang B; Shi G; Zhang C; Li G; Huang M
Amino Acids; 2022 Jan; 54(1):1-11. PubMed ID: 34837554
[TBL] [Abstract][Full Text] [Related]
16. Protective role of SIRT5 against motor deficit and dopaminergic degeneration in MPTP-induced mice model of Parkinson's disease.
Liu L; Peritore C; Ginsberg J; Shih J; Arun S; Donmez G
Behav Brain Res; 2015 Mar; 281():215-21. PubMed ID: 25541039
[TBL] [Abstract][Full Text] [Related]
17. Therapies modulating insulin resistance in Parkinson's disease: A cross talk.
Sharma T; Kaur D; Grewal AK; Singh TG
Neurosci Lett; 2021 Apr; 749():135754. PubMed ID: 33610666
[TBL] [Abstract][Full Text] [Related]
18. Antagonistic pleiotropic effects of nitric oxide in the pathophysiology of Parkinson's disease.
Tripathy D; Chakraborty J; Mohanakumar KP
Free Radic Res; 2015; 49(9):1129-39. PubMed ID: 25968946
[TBL] [Abstract][Full Text] [Related]
19. Nootkatone alleviates rotenone-induced Parkinson's disease symptoms through activation of the PI3K/Akt signaling pathway.
Yao Z; Li J; Bian L; Li Q; Wang X; Yang X; Wei X; Wan G; Wang Y; Shi J; Guo J
Phytother Res; 2022 Nov; 36(11):4183-4200. PubMed ID: 35833337
[TBL] [Abstract][Full Text] [Related]
20. Targeting G Protein-Coupled Receptors in the Treatment of Parkinson's Disease.
Jones-Tabah J
J Mol Biol; 2023 Jun; 435(12):167927. PubMed ID: 36563742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
